Media
The latest news, announcements and media resources
Here you will find a range of resources including our latest and archived press releases, information on our social media channels, and our photo and video library.
Key information
Press releases
- GSK ships 2019-20 seasonal influenza vaccines for US market
- IAS 2019: ViiV Healthcare showcasing innovation in HIV science
- GSK announces positive headline results in Phase 3 PRIMA study of ZEJULA (niraparib) for patients with ovarian cancer in the first line maintenance setting
GSK US Twitter
-
GSKUS @GSKUS
Live from the team at Marietta #PA: We’re excited to be shipping the 1st of more than 40 million doses of #flu #vaccine to vaccinate patients for the upcoming 2019-2020 flu season. 🚚gsk.to/2ljjbt8Jb
about 13 hours ago -
GSKUS @GSKUS
It feels like classes JUST ended, but why not schedule 📅#wellnesss visits now, so that you and your teen can focus on#summerr fun?#Take5forMeningitiss and talk to your teen’s doc about recommended vaccines like#MenBB & visitgsk.to/2xKtDwu0 to learn more. n5
about 18 hours ago
-
GSK in the US
GSK is dedicated to helping grow the US economy and supporting communities by creating high-quality jobs in areas like R&D, manufacturing, and sales.
-
Pharmaceuticals
Our Pharmaceuticals business is made up of innovative and established medicines and holds leading market positions in respiratory disease and HIV.
-
Vaccines
Our Vaccines business has a broad portfolio and innovative pipeline of vaccines to protect people of all ages. We deliver over two million vaccine doses per day to people living in over 160 countries.
-
Consumer Healthcare
Our Consumer Healthcare business develops and markets consumer preferred and expert recommended brands in the Oral health, Pain relief, Respiratory, Nutrition/gastro-intestinal and Skin health categories.
